Gender differences in vascular disease: Not a simple explanation

Journal of Hypertension

Volumn 25, Issue 6, 2007, Pages 1193-1194

  Van Den Meiracker, Anton H ^a   De Ronde, Willem ^b  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; PROGESTERONE; TESTOSTERONE; THIOREDOXIN;

ANGIOTENSIN BLOOD LEVEL; BLOOD PRESSURE MEASUREMENT; EDITORIAL; HORMONE SUBSTITUTION; HUMAN; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PATHOPHYSIOLOGY; POSTMENOPAUSE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEX DIFFERENCE; UPREGULATION; VASCULAR DISEASE;

EID: 34250327068     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/HJH.0b013e32812908d3     Document Type: Editorial

References (17)

1. World CJ, Yamawaki H. Thioredoxin in the cardiovascular system. J Mol Med 2006; 84:997-1003.
2. Hokamaki J, Kawano H, Soejima H, Miyamoto S, Kajiwara I, Kojima S, et al. Plasma thioredoxin levels in patients with unstable angina. Int J Cardiol 2005; 99:225-231.
3. Jekell A, Hossain A, Alehagen U, Dahlstrom U, Rosen A. Elevated circulating levels of thioredoxin and stress in chronic heart failure. Eur J Heart Fail 2004; 6:883-890.
4. Ejima K, Nanri H, Araki M, Uchida K, Kashimura M, Ikeda M. 17 beta-estradiol induces protein thiol/disulfide oxidoreductases and protect cultured bovin aortic endothelial cells from oxidative stress. Eur J Endocrinol 1999; 140:608-613.
5. Deroo BJ, Hewitt SC, Peddada SD, Korach KS. Estradiol regulates the thioredoxin antioxidant system in mouse uterus. Endocrinology 2004; 145:5485-5492.
6. Mollnau H, Wendt M, Szocs K, Lassegue B, Schultz E, Oelze M, et al. Effects of angiotensin II infusion on the expression and function of NAD (P)H oxidase and components of nitric oxid/cGMP signalling. Circ Res 2002; 90:E58-E65.
7. Schulman IH, Zhou MS, Raij L. Interaction between nitric oxide and angiotensin II in the endothelium: role in atherosclerosis and hypertension. J Hypertens 2006; 24 (Suppl):S45-S50.
8. Fukai T, Siegfried MR, Ushio-Fukai M, Griending KK, Harison DG. Modulation of extracellular superoxide dismutase expression by angiotensin II and hypertension. Circ Res 1999; 85:23-28.
9. Ebrahimian T, He Y, Schiffrin EL, Touyz RM. Differential regulation of thioredoxin and NAD (P)H oxidase by angiotensin II in male and female mice. J Hypertens 2007; 25:1263-1271.
10. Pamidimukkala J, Taylor JA, Welshons WV, Lubahn DB, Hay M. Estrogen modulation of baroreflex function in conscious mice. Am J Physiol Regul Integr Comp Physiol 2003; 284:R983-R989.
11. Wiinber N, Hoegholm A, Christensen HR, Bang LE, Mikkelsen KL, Nielsen PE, et al. 24-h ambulatory blood pressure in 52 normal Danish subjects, related to age and gender. Am J Hypertens 1995; 8:978-986.
12. Stampfer MJ, Golditz, Willett WC, Manson JE, Rosner B, Speizer FE, Hennekens CH. Postmenopausal estrogen therapy and cardiovascular disease: 10 year follow-up from Nurses' Health Study. N Engl J Med 1991; 325:756-762.
13. Mendelsohn ME, Karas RH. The protective effects of estrogen on the cardiovascular system. N Engl J Med 1999; 340:1801-1811.
14. Rossouw JE. Hormones, genetic factors, and gender differences in cardiovascular disease. Cardiovasc Res 2002; 53:550-557.
15. Mendelsohn ME. Nongenomic estrogen receptor mediated activation of endothelial nitric oxide synthase. How does it work? What does it mean? Circ Res 2000; 87:677-682.
16. Huang A, Sun D, Koller A, Kaley G. 17beta-estradiol restores endothelial nitric oxide release to shear stress in arterioles of male hypertensive rats. Circulation 2000; 101:94-100.
17. Farquhar CM, Marjoribanks J, Lethaby A, Lambets Q, Suckling JA, for the Cochrane HT Study Group. Long term hormone therapy for perimenopausal and postmenopausal women. Cochrane Database Syst Rev 2005; 3:CD004143.